Tyr-762 is an autophosphorylation site in the human platelet-derived growth factor (PDGF) a-receptor. In order to investigate whether phosphorylated Tyr-762 serves as a docking site for downstream signal transduction molecules, anity puri®cation using an immobilized synthetic peptide containing phosphorylated Tyr-762 and its surrounding amino acid residues was performed. Proteins in HeLa cell lysate of molecular sizes 27, 38 and 40 kDa bound to the phosphorylated, but not to the unphosphorylated peptide. Analyses of partial amino acid sequences of the puri®ed proteins indicated that they were identical to CrkI, CrkII and CrkL respectively. The wild-type PDGF a-receptor, when expressed in porcine aortic endothelial cells, formed complexes with CrkII and CrkL upon ligand stimulation, which was speci®cally inhibited by a synthetic peptide containing phosphorylated Tyr-762. Replacement of Tyr-762 with a phenylalanine residue in the PDGF a-receptor abrogated ligand-induced binding of Crk proteins. Tyrosine phosphorylation of CrkII and CrkL increased by 1.8-and 1.3-fold, respectively, upon ligand stimulation of the wild-type areceptor. In contrast, the Y762F mutant PDGF areceptor failed to induce tyrosine phosphorylation of Crk proteins. CrkII and CrkL constitutively formed complex with the guanine nucleotide exchange factor C3G, in unstimulated as well as PDGF-stimulated cells. Moreover, the activated wild-type PDGF a-receptor but not the Y762F mutant receptor was found in a C3G immunoprecipitate, suggesting that a ternary complex between the activated PDGF a-receptor, Crk and C3G was formed. DNA synthesis stimulated by PDGF-BB as well as PDGF-induced MAP kinase activation was similar in cells expressing wild-type and mutant receptors. Interestingly, the activated PDGF b-receptor was found not to bind Crk proteins. Instead, Tyr-771 of the b-receptor, which is localized at an analogous position to Tyr-762 in the a-receptor, binds RasGAP. RasGAP is not bound to the a-receptor.
Introduction
Platelet-derived growth factor (PDGF) is a potent mitogen for cells of mesenchymal origin, and has recently been shown to act also on other types of cells (Beits et al., 1991; Do et al., 1992; Heldin et al., 1981; Henriksen et al., 1993; Ra et al., 1988; Smits et al., 1991) . It is implicated in normal embryonic development and wound healing, as well as in development of pathological conditions such as tumors, in¯ammatory diseases and atherosclerosis (Heldin and Westermark, 1994; Ross, 1993) . PDGF is a family of isoforms consisting of homo-or hetero-dimeric proteins of Aand B-polypeptide chains, which bind in a dierential manner to two structurally related cell surface receptors, thereby inducing dimerization and activation of the receptors (Claesson-Welsh, 1994) . The PDGF b-receptor preferentially binds to the PDGF Bchain, whereas the a-receptor binds both A-and Bchains with high anity. As a result, PDGF-AA induces aa-receptor homodimers, PDGF-AB aahomodimers and ab-heterodimers, and PDGF-BB assembles all three possible combinations of receptor dimers. Receptor dimerization induces upregulation of the intrinsic tyrosine kinase activity of the receptors which leads to tyrosine phosphorylation of various intracellular proteins as well as receptor autophosphorylation. The autophosphorylation sites serve as speci®c binding sites for Src Homology 2 (SH2) domains which are found in certain intracellular signaling proteins (Margolis, 1992; Pawson, 1995) . Interactions between the receptors and SH2 domaincontaining molecules activate dierent signal transduction pathways which lead to various biological activities.
Many studies on cultured cells have given examples of functional dierences between PDGF a-and breceptors. While both PDGF a-and b-receptors are able to initiate DNA synthesis (Hosang et al., 1989; Matsui et al., 1989) , it has been reported that the breceptor is a more potent mediator of mitogenicity compared to the a-receptor in certain cell types (Heidaran et al., 1993; Inui et al., 1994) . Moreover, whereas the b-receptor mediates stimulation of chemotaxis, a-receptor inhibits chemotaxis, at least in certain cell types (Eriksson et al., 1992; Koyama et al., 1992; Siegbahn et al., 1990) . The two types of receptors also dier in their ability to mediate intracellular calcium mobilization and protein kinase C activation (Block et al., 1989; Diliberto et al., 1992; Salhany et al., 1992) .
The basis of the functional dierences may lie in distinct properties of signaling cascades engaged by each receptor. Most of the information regarding signal transduction by the PDGF receptors is based on studies on the PDGF b-receptor (Claesson-Welsh, 1994) . Autophosphorylation of the PDGF b-receptor leads to direct binding of phosphatidylinositol 3'-kinase (PI3K), phospholipase C-g (PLC-g), Src family tyrosine kinases, GTPase-activating protein for Ras (RasGAP), the protein tyrosine phosphatase SHP-2, and the adaptor molecules Grb2 and Shc, and the respective binding sites have been identi®ed (Claesson-Welsh, 1994) . Among these signal transduction molecules, at least PI3K, PLC-g and SHP-2 also bind to the areceptor (Baznet et al., 1995; Eriksson et al., 1992; Yu et al., 1991) . During an analysis of autophosphorylation sites in the a-receptor involved in stimulatory and inhibitory signals for chemotaxis (Yokote et al., 1966) , we noticed that Tyr-762 in the receptor is an autophosphorylation site. Since the sequence surrounding Tyr-762 is not conserved in the b-receptor, we explored the possibility that Tyr-762 mediates areceptor speci®c signals. We report here that members of Crk family of adaptor molecules bind to phosphorylated Tyr-762 of the a-receptor, but do not bind to the b-receptor.
Results
Puri®cation of intracellular proteins which speci®cally recognize phosphorylated Tyr-762 in the human PDGF a-receptor
We have previously shown that Tyr-762 in the human PDGF a-receptor becomes autophosphorylated in vivo upon ligand stimulation (Yokote et al., 1996) . In order to identify proteins which bind to phosphorylated Tyr-762 in the a-receptor, phosphorylated (pY762) or unphosphorylated (Y762) peptides containing Tyr-762 and its surrounding amino acid sequences covalently coupled to agarose beads, were incubated with [ 35 S]cysteine/methionine-labeled HeLa cell lysate. The material bound to the agarose beads was subjected to SDS ± PAGE and analysed by autoradiography. As shown in Figure 1a , proteins of three dierent molecular sizes, p27, p38 and p40, were found to bind to the pY762 peptide or to uncoupled agarose. Moreover, the association of these proteins to pY762 peptide immobilized on agarose, but not to the Y762 peptide-coupled beads, could be completely inhibited by the addition of free pY762 peptide, but was not aected by addition of Y762 peptide. These results suggest that the proteins bind speci®cally to the peptide and that the interaction is strictly dependent on phosphorylation of Tyr-762. In order to purify the components binding to phosphorylated Tyr-762 in large scale, a lysate from 10 10 HeLa cells was used as starting material. The SDS ± PAGE analysis followed by Coomassie blue staining of material bound to immobilized pY762 peptide revealed components of 27, 38 and 40 kDa (data not shown). The protein bands were then cut from the wet polyacrylamide gel and subjected to in gel digestion using endoproteinase LysC. The proteolytic fragments were separated by reversed phase chromatography, and selected peptides were then subjected to amino acid sequencing ( Figure  1b ). Searches in a data base revealed that the analysed partial amino acid sequences of p27, p38 and p40 were identical to internal sequences found in human CrkI, CrkII and CrkL proteins, respectively (Figure 1c) . The Crk family of adaptor molecules consists of CrkI with one SH2 and one SH3 domains and CrkII and CrkL with one SH2 and two SH3 domains each (Matsuda et al., 1992; Reichman et al., 1992; ten Hoeve et al., 1993) . CrkI and CrkII are dierent splice variants of the same gene, whereas CrkL is derived from a distinct gene.
Crk proteins associate with phosphorylated Tyr-762 in the PDGF a-receptor in vivo Crk proteins are known to bind to several tyrosinephosphorylated proteins via their SH2 domains. In order to examine whether they bind to the PDGF areceptor in vivo, porcine aortic endothelial (PAE) cells expressing the wild-type PDGF a-receptor, untreated or treated with PDGF-BB, were lysed and subjected to immunoprecipitation with either anti-CrkII or antiCrkL antibodies. The immunoprecipitates were analysed by SDS ± PAGE, and then transferred onto a nitrocellulose ®lter. The ®lter was immunoblotted with an antibody which speci®cally recognizes the PDGF a-receptor. As shown in Figure 2a , upper panel, both CrkII and CrkL were coprecipitated with the PDGF a-receptor in a ligand-dependent manner. Immunoblotting of the same ®lter with anti-CrkII and CrkL antibodies showed that equal amounts of Crk proteins were immunoprecipitated from stimulated and nonstimulated cells (Figure 2a, lower panel) . The Crk proteins appeared as double bands, which most likely represent a faster migrating nonphosphorylated form and a slower migrating phosphyorylated form, as judged from immunoblotting of the same ®lter using phosphotyrosine antibodies (data not shown). The anti-CrkII antibody used in this experiment does not cross-react with CrkI according to manufacturer's information. Because CrkI and CrkII have identical SH2 domains which are responsible for the binding to tyrosine phosphorylated proteins (Matsuda et al., 1992) , it is likely, however, that also CrkI would bind to the PDGF areceptor.
We next examined whether the binding of Crk proteins to the autophosphorylated PDGF a-receptor could be disrupted by addition of synthetic peptides corresponding to Tyr-762 and its surrounding amino acids. PAE cells expressing the wild-type PDGF areceptor were treated with PDGF-BB, lysed and incubated with various doses of phosphorylated or unphosphorylated peptides for 1 h at 48C. Thereafter, the lysates were immunoprecipitated with either antiCrkII or anti-CrkL antibodies, analysed by SDS ± PAGE, and then immunoblotted with a PDGF areceptor antibody. As shown in Figure 2b and c, a phosphorylated Tyr-762 peptide (pY762) dose-dependently disrupted complex formation between the PDGF a-receptor and CrkII or CrkL, whereas the unphosphorylated control peptide (Y762) showed no eect. Another phosphorylated peptide, pY988, which contains another autophosphorylation site in the areceptor (Eriksson et al., 1995; Yokote et al., 1996) , did not either show any eect. The results suggest that Crk proteins speci®cally recognize phosphorylated Tyr-762 in the PDGF a-receptor in vivo.
In order to examine the role of Tyr-762 in the PDGF a-receptor for the binding as well as tyrosine phosphorylation of Crk proteins, a mutant PDGF areceptor in which Tyr-762 was replaced with a phenylalanine residue (Y762F mutant) was constructed and stably transfected into PAE cells. As shown in Figure 3a , both the wild-type and Y762F mutant PDGF a-receptors were expressed at similar levels, and both types of receptors underwent autophosphorylation upon treatment with PDGF-BB. In order to investigate whether wild-type and mutant areceptors mediate binding or phosphorylation of Crk molecules, cells were treated with PDGF-BB, lysed, and immunoprecipitated using antibodies against CrkII or CrkL; the samples were then analysed by immunoblotting using an anti-phosphotyrosine antibody. The wild-type but not the Y762F mutant receptor formed complex with either CrkII or CrkL upon ligand stimulation (Figure 3b and c) . Tyrosine phosphorylation of CrkII and CrkL increased by 1.5-and 1.3-fold, respectively, upon ligand treatment of the wild-type receptor-expressing cells. In contrast, no ligand-induced tyrosine phosphorylation of Crk proteins was observed in the cells expressing Y762F mutant (Figure 3b and c) . ]methionine/ cysteine-labeled HeLa cells were lysed, precleared and incubated for 2 h at 48C with agarose beads either uncoupled or coupled with phosphorylated (pY762) or nonphosphorylated (Y762) peptides. For the competition experiment, either phosphorylated (pY762) or unphosphorylated (Y762) peptides were added to the lysate at ®nal concentrations of 100 mM during the incubation. The beads were then washed thoroughly and the bound material was subjected to SDS ± PAGE using a 5 ± 20% acrylamide gel. The gel was dried and analysed by autoradiography. p27, p38 and p40 indicate positions of the proteins which bound to the pY762 peptide in a phosphorylation dependent manner. The positions of molecular mass markers are also indicated. (b) Narrow-bore liquid chromatography of peptides obtained by digestion with endoproteinase LysC of the proteins in the gel bands labeled p27, p38 and p40. The marked fractions were selected for Edman degradation, and their sequences are given. Fractions marked 1 were considered identical and pooled prior to sequence analysis. The peptide isolation was performed on a mRPC C2/c18 SC2.1/10 column in SMART System. Flow rate was 100 ml/min and the sample was eluted by a linear gradient of acetonitrile in 0.06% tri¯uoroacetic acid. (c) Schematic illustration of the structure of CrkI, CrkII and CrkL. Arrows indicate locations of the amino acid sequences obtained above. p27-1 and -2 peptides corresponded to amino acid residues 179 ± 188 and 190 ± 204 in CrkI, respectively. p38-1 and -3 peptides corresponded to amino acid residues 179 ± 188 and 254 ± 265 in CrkII, respectively. p40-4 and -5 peptides corresponded to amino acid residues 167 ± 180 and 254 ± 265 in CrkL, respectively. Boxes show the positions of the SH2 and SH3 domains Tyrosine phosphorylated components of 120 ± 130 kDa were constitutively coprecipitated with Crk proteins (Figure 3b and c). Reprobing of the same blots with an antiserum against p130Cas (Sakai et al., 1994) revealed that at least a component of the bands corresponds to p130Cas (data not shown). However, the identity of the other components remain unclear.
Crk does not bind to the PDGF b-receptor
Next, we examined whether Crk molecules bind to the PDGF b-receptor in vivo. PAE cells expressing either the wild-type PDGF a-or b-receptor, untreated or treated with PDGF-BB, were lysed and subjected to immunoprecipitation with either anti-receptor, antiCrkII or anti-CrkL antibodies. The immunoprecipitates were analysed by SDS ± PAGE, and then transferred onto a nitrocellulose ®lter. The ®lter was immunoblotted with anti-phosphotyrosine antibody. As shown in Figure 4a , both PDGF a-and breceptors underwent tyrosine phosphorylation to the similar extent upon PDGF treatment. Neither CrkII nor CrkL were coprecipitated with the activated PDGF b-receptor, whereas the activated PDGF a-receptor was found in Crk immunoprecipitates. However, tyrosine phosphorylation of CrkII and CrkL increased by 4.8-and 3.2-fold, respectively, upon ligand treatment of the b-receptor-expressing cells.
RasGAP does not bind to the PDGF a-receptor
Tyr-762 in the PDGF a-receptor is localized in an analogous position as Tyr-771 in the PDGF b-receptor, which after phosphorylation binds GTPase-activating protein for Ras (RasGAP) (Kazlauskas et al., 1990) . In order to investigate whether RasGAP also binds to the areceptor, lysates from PAE cells expressing a-or breceptors were immunoprecipitated with either antiRasGAP antibody or with anti-PDGF receptor antibodies. The immunoprecipitates were subjected to SDS ± Complex formation between the activated PDGF a-receptor and Crk proteins in vivo, and its speci®c inhibition by a peptide containing phosphorylated Tyr-762. (a) PAE cells expressing the wild-type PDGF a-receptor were incubated without (7) or with (+) 100 ng/ml PDGF-BB for 30 min at 48C. The cells were lysed and subjected to immunoprecipitation using either anti-CrkII or CrkL antibodies. The immunoprecipitates were analysed by SDS ± PAGE using a 5 ± 12% acrylamide gel and then transferred onto nitrocellulose ®lter. The high molecular weight region of the ®lter was immunoblotted with anti-PDGF a-receptor antibody 951 and the low molecular weight region was blotted with a mixture of anti-CrkII and CrkL antibodies. Positions of the PDGF areceptor (aR), CrkII and CrkL are indicated. IP; immunoprecipitation, IB; immunoblotting. (b) PAE cells expressing the wild-type PDGF a-receptor were incubated without (7) or with (+) 100 ng/ml PDGF-BB for 5 min at 378C. The cells were lysed and incubated with various doses of phosphorylated or unphosphorylated peptides for 1 h at 48C. The lysates were then subjected to immunoprecipitation using anti-CrkII antibody. The immunoprecipitates were analysed by SDS ± PAGE using a 5 ± 12% acrylamide gel and transferred onto nitrocellulose ®lter. The high molecular weight region of the ®lter was immunoblotted with anti-PDGF areceptor antibody 951 and the low molecular weight region was blotted with anti-CrkII antibody. IP; immunoprecipitation, IB; immunoblotting. (c) The assay conditions were the same as those for (b), except that anti-CrkL antibody was used instead of antiCrk II antibody PAGE, transferred onto nitrocellulose membrane and then immunoblotted with anti-phosphotyrosine antibody. As shown in Figure 4b , a tyrosine phosphorylated band of about 190 kDa, which comigrated with and most likely represented the autophosphorylated breceptor, coprecipitated with RasGAP upon ligand treatment of the b-receptor-expressing cells. Ligand stimulation of the b-receptor also resulted in increased tyrosine phosphorylation of RasGAP. In contrast, the activated PDGF a-receptor was not coprecipitated with or induced tyrosine phosphorylation of RasGAP. This binding is consistent with previous observations (Baznet and Heidaran et al., 1993) . Thus, the region in the kinase inserts of the PDGF a-or breceptors where Tyr-762 and Tyr-771, respectively, are localized, may be important for diferential signaling from the receptors.
A guanine nucleotide exchange factor C3G forms complex with Crk proteins and the autophosphorylated PDGF a-receptor Several intracellular proteins are known to associate with the SH3 domains of the Crk proteins, including the guanine nucleotide exchange factor C3G Tanaka et al., 1994) . C3G has been shown to be an activator of a Ras-related small G protein Rap 1. In order to examine the possible involvement of C3G in PDGF a-receptor signaling, cells expressing the wild-type PDGF a-receptor was treated or not with PDGF-BB, lysed and immunoprecipitated with antibodies against CrkII or CrkL; the immunoprecipitates were then subjected to SDS ± PAGE and immunoblotting with a speci®c antibody for C3G. Figure 5a shows that both CrkII and CrkL could be precipitated in complex with coprecipitated C3G. The amount of coprecipitated C3G was not aected by PDGF stimulation, suggesting that a constitutive complex between C3G and Crk occurs. Next we examined whether the Crk-C3G complex is recruited to the PDGF a-receptor upon ligand stimulation. After PDGF stimulation, a tyrosine-phosphorylated protein most likely represents the autophosphorylated wildtype PDGF a-receptor was seen in C3G immunoprecipitates (Figure 5b ), suggesting that a ternary complex consisting of C3G, Crk protein and the a-receptor is formed. Considerably less of the Y762F mutant receptor compared to the wild-type receptor was coprecipitated with C3G, suggesting that Tyr-762 is involved in the formation of the ternary complex (Figure 5b ). The wild-type PDGF b-receptor was also found to be coprecipitated with C3G upon ligandstimulation (Figure 5b) .
Stimulation of DNA synthesis and activation of MAP kinase in Y762F mutant receptor cells
In order to examine the functional role of the interaction between Crk and the PDGF a-receptor, cells expressing the wild-type or Y762F mutant PDGF a-receptor were examined for ligand-induced stimulation of [ 3 H]thymidine incorporation. Both the wildtype and Y762F mutant receptors responded mitogenically to PDGF-BB, in a dose-dependent manner (Figure 6a ). The average response in six dierent clones expressing the Y762F receptor mutant cells was lower than the average of six dierent clones with the wild-type receptors, but the dierence was not signi®cant.
Activation of MAP kinase upon PDGF-BB stimulation, estimated by phosphorylation of myelin basic protein by anti-MAP2 kinase immunoprecipitates, was similar in the cells expressing either the wild-type or T762F mutant PDGF a-receptors (Figure 6b ). 
IB:
Figure 3 Y762F PDGF a-receptor fails to associate with or phosphorylate Crk proteins upon ligand stimulation. (a) PAE cells expressing the wild-type or Y762F mutant PDGF a-receptor were incubated without (7) or with (+) 100 ng/ml PDGF-BB for 5 min at 378C. The cells were lysed and the glycoproteins were recovered using wheat germ agglutinin (WGA). The samples were separated by SDS ± PAGE and transferred onto nitrocellulose ®lter. The blots were immunoblotted using either anti-PDGF areceptor antibody 951 (left panel) or with an anti-phosphotyrosine monoclonal antibody (right panel). (b) Cells expressing either the wild-type or Y762F mutant PDGF a-receptors were incubated with 100 ng/ml PDGF-BB for 5 min at 378C. The cells were lysed and subjected to immunoprecipitation using anti-CrkII antibody. The immunoprecipitates were analysed by 5 ± 12% SDS ± PAGE and then transferred onto nitrocellulose ®lter. The ®lter was immunoblotted with an anti-phosphotyrosine antibody (4G10). (c) The assay conditions were the same as those for (b), except that anti-CrkL antibody was used instead of anti-CrkII antibody
Discussion
In this study, we show that the activated PDGF areceptor, but not the b-receptor, forms complex with members of the Crk family of adaptor proteins. Since Crk proteins constitutively bind the guanine nucleotide exchange factor C3G, a ternary complex between the activated a-receptor, Crk and C3G is formed. Crk molecules were found to bind to a phosphorylated peptide containing Tyr-762, and a Y762F mutant receptor was unable to bind and phosphorylate Crk molecules in vivo, indicating that Tyr-762 serves as the only binding site for Crk molecules. Interestingly, the ability of the mutated receptor to mediate a growth response was decreased, despite the fact that it retained full ability to activate the MAP kinase cascade.
Crk is a family of structurally related adaptor molecules, consisting of CrkI and CrkII which are dierent splice products of the same gene, and CrkL which is the product of a distinct gene (Matsuda et al., 1992; Reichman et al., 1992; ten Hoeve et al., 1993) . The ®rst member of the family, v-Crk, was identi®ed as the transforming protein of the avian retrovirus CT10 (Mayer et al., 1988) . Subsequent studies have shown that overexpression of v-Crk or CrkI, but not CrkII, leads to transformation of cells (Matsuda et al., 1992) . CrkL has been implicated in development of chronic myelogenous leukemia (Nichols et al., 1994; Oda et al., 1994; Salgia et al., 1995; ten Hoeve et al., 1994) . The presence of both SH2 and SH3 domains in Crk proteins is of crucial importance for their function as adaptor molecules (Tanaka et al., 1993 (Tanaka et al., , 1995 . The SH2 domains of Crk molecules have been shown to bind to several phosphorylated proteins, including p130Cas, Cbl and the focal adhesion protein paxillin Buday et al., 1996; Ribon et al., 1996; Sakai et al., 1994; Smit et al., 1996b) . The SH3 domains have been shown to bind to e.g. the cytoplasmic tyrosine kinase c-Abl, the adaptor molecule DOCK180, and the guanine nucleotide exchange factor C3G and Sos (Feller et al., 1994; Hasegawa et al., 1996; Knudsen et al., 1995; Matsuda et al., 1996; Reedquist et al., 1996; Tanaka et al., 1994) .
Among the potential eector molecules of Crk, the guanine nucleotide exchange factors are of special interest. Crk binds to Sos, which acts on Ras Matsuda et al., 1994) . However, it appears that Sos is a major eector of another adaptor molecule, Grb2 (Buday and Downward, 1993; Lowenstein et al., 1992) . In the case of the Grb2/Sos complex, a key event which leads to activation of Ras, is the translocation of the Grb2/Sos complex to the plasma membrane. Of potential physiological signi®cance is the binding of Crk to C3G, which occurs with high speci®city and has been shown to occur in vivo Reedquist et al., 1996; Smit et al., 1996a) . The present study is the ®rst demonstration that C3G is recruited to a tyrosine kinase receptor via Crk. It remains to be elucidated whether the translocation of the Crk/C3G complex to the cell membrane is of similar importance as the translocation of the Grb2/Sos complex. To our surprise, the wildtype PDGF b-receptor was also found to be coprecipitated with C3G upon ligand-stimulation (Figure 5b ). Because Crk does not bind to the breceptor, it is likely that C3G-receptor complex formation is mediated by other component(s) than Crk in the case of PDGF b-receptor.
C3G has been shown to activate a Ras-related small G protein, Rap1, whose precise biologial function still is unclear (Gotoh et al., 1995) . Rap1 was originally identi®ed as Krev-1 for its ability to revert v-Ki-Rasinduced transformation of ®broblasts (Kitayama et al., 1989) . However, Rap1 has also been connected with (7) or with (+) 100 ng/ml PDGF-BB for 5 min at 378C. The cells were lysed and subjected to immunoprecipitation using either antiCrkII or CrkL antibodies. The immunoprecipitates were analysed by SDS ± PAGE using a 7.5% acrylamide gel and transferred onto nitrocellulose ®lter. The ®lter was immunoblotted with anti-C3G antibody. The positions of C3G is indicated. (b) Cells expressing either the wild-type PDGF a-receptor, Y762F mutant PDGF a-receptors or the wild-type PDGF b-receptor were incubated without (7) or with (+) 100 ng/ml PDGF-BB for 5 min at 378C. The cells were lysed and subjected to immunoprecipitation using an anti-C3G antibody. The immunoprecipitates were analysed by 7.5% SDS ± PAGE and then transferred onto nitrocellulose ®lter. The ®lter was immunoblotted with an anti-phosphotyrosine antibody (PY20). The same ®lter was probed with an anti-C3G antibody after stripping, in order to con®rm equal loading of C3G in the each lane mutant PDGF a-receptor were incubated with (+) or without (7) 50 ng/ml of PDGF-BB for 5 min at 378C, lysed and immunoprecipitated using an antiserum against MAP kinase (EET). The samples were subjected to a kinase assay using an exogenous substrate, myelin basic protein (MBP), and then analysed by SDS ± PAGE using a 15% acrylamide gel. The radioactivities incorporated into the MBP bands were measured by using a Bioimage analyser BAS2000 (Fuji ®lm) and presented as fold increases. The position of MBP was indicated stimulation of DNA synthesis . We are currently investigating whether Rap1 is activated downstream of the PDGF a-receptor. Ligand treatment of the wild-type PDGF a-receptor resulted in formation of the receptor/Crk protein complex as well as increased tyrosine phosphorylation of Crk proteins (Figure 3b and c) . However the mutant receptor in which Tyr-762 was replaced with a phenylalanine residue was no longer able to associate with or phosphorylate Crk proteins (Figure 3b and c) . These results suggest that Tyr-762 is the only binding site for Crk proteins in the PDGF a-receptor and that interaction with phosphorylated Tyr-762 is important also for tyrosine phosphorylation of Crk proteins.
Tyr-762 in the PDGF a-receptor is localized at a position analogous to that of Tyr-771 in the b-receptor, however, the sequences downstream of the two tyrosine residues, which determine the speci®city for binding of SH2 domains Waksman et al., 1992) , dier. Whereas Tyr-771 of the b-receptor binds RasGAP (Figure 5b , Kazlauskas et al., 1990) , the areceptor does not bind RasGAP (Figure 5b , Baznet et al., 1993; Heidaran et al., 1993) . On the other hand, Crk which binds to Tyr-762 of the a-receptor, does not bind to the b-receptor (Figure 6a ). This is consistent with the fact that the sequence around Tyr-762 in the a-receptor (Tyr762-Asp-Arg-Pro) is compatible with the consensus sequence for binding of the SH2 domain of Crk (TyrAsp-His-Pro) , whereas the sequence around Tyr-771 in the b-receptor is divergent (Tyr771-Met-Ala-Pro). Despite lack of binding, however, Crk molecules become tyrosine phosphorylated by the activated b-receptor. A possible explanation is that Crk binds to the b-receptor only transiently or with a low anity, so that the interaction cannot be detected by conventional immunoprecipitation. The possibility is consistent with the fact that Tyr-771 in the b-receptor satis®es the minimal reqirement for the binding site for Crk SH2 domain, i.e. presence of a proline residue at the third position carboxyterminal of the phosphorylated tyrosine residues.
Most of the SH2 domain-containing signal transduction molecules that are known to bind to PDGF receptors, bind to both a-and b-receptors. RasGAP and Crk are examples of signaling molecules which bind to the receptors in a dierential manner ( Figure  7) ; further studies of their roles in intracellular signaling may unravel the molecular mechanism for the partly dierent functional roles of the a-and the b-receptors, e.g. in regulation of chemotaxis.
An involvement of Crk in mitogenic signaling has also been suggested by the ®nding that overexpression of CrkII in ®broblasts resulted in an enhancement of IGF-I-induced DNA synthesis (Beitner-Johnson et al., 1996) . Activation of Ras and the MAP kinase cascade have been shown to be important in PDGF-induced mitogenicity (Arvidsson et al., 1994; Valius and Kazlauskas, 1993) . However, no signi®cant alteration in ability to mediate cell growth as well as MAP kinase activation was seen in Y762F mutant receptor cells. Further studies will be aimed at elucidating the importance of Crk in signaling downstream of the PDGF a-receptor.
Materials and methods

Plasmids and cell culture
Site-directed mutagenesis was performed on a cDNA encoding the full-length human PDGF a-receptor cDNA (Claesson-Welsh et al., 1989) using Altered sites in vitro Mutagenesis System (Promega Corp., USA). An oligonucleotide 5' -CAG AGA TCA CTC TTT GAT CGTC-CAGCCTCA -3' was used to introduce the Y762F mutation into the PDGF a-receptor cDNA. The mutation was con®rmed by DNA sequencing. The wild-type or Y762F mutant PDGF a-receptor cDNA were inserted into the CMV promoter-based eukaryotic expression vector pcDNA3 (Invitrogen, The Netherlands) by use of BamHI sites. The PDGF a-receptor constructs were transfected into PAE cells (Miyazono et al., 1987) , which lack endogenous PDGF receptors, using the Lipofectamine (Gibco BRL, USA) method. Stable transfectants were obtained through selection with geneticin (G418, Gibco), according to the manufacturer's instruction. Selection of positive clones using 125 I-PDGF-BB (Amersham, England), and the following expansion as well as maintenance of the cell lines was performed as previously decribed (Mori et al., 1991) . PAE cells expressing the wild-type PDGF b-receptor has already been described (Mori et al., 1993) . HeLa cells were obtained from American Tissue Culture Collection and maintained in Dulbecco's modi®ed Eagle's medium supplemented with 10% fetal bovine serum (FBS, Gibco). For serum starvation, subcon¯uent cultures of cells were incubated in Ham's F-12 medium containing 0.5% FBS for 16 h.
Antibodies and reagents
The peptide antiserum R3, raised against the carboxyterminal tail of PDGF b-receptor, and the antiserum R7, against the PDGF a-receptor, have been described previously (Eriksson et al., 1992; Mori et al., 1993 ). An anti-PDGF areceptor antibody, 951, as well as antibodies against CrkII, CrkL, C3G or RasGAP were purchased from Santa Cruz Biotechnology Inc (USA). The monoclonal anti-phosphotyrosine antibodies 4G10 and PY20 were from Upstate Biotechnology Inc. (USA) and from Transduction Laboratories, (USA), respectively. An antibody against p130Cas was a kind gift from Dr, Hisamaru Hirai (University of Tokyo, Japan). Peroxidase-conjugated sheep anti-mouse immunoglobulin and peroxidase-conjugated donkey antirabbit immunoglobulin were from Amersham Corp. Human recombinant PDGF-BB was purchased from R&D System (USA).
Peptide synthesis
The following synthetic peptides, phosphorylated at tyrosine residues (indicated as pY), were used in this study:
The peptides were synthesized by Fmoc (9-fluorenylmethoxycarbonyl) chemistry and phosphorylated by use of the global phosphorylation method (Andrews et al., 1991; Kitas et al., 1991) using di-t-butyl-N,-N-diisopropylphosphoramidite, as previously described (Mori et al., 1993) . The corresponding unphosphorylated peptides were also synthesized and used as controls.
Immobilization of peptides on agarose beads
Immobilization of synthetic peptides on agarose beads (Agel-15, Bio-Rad, USA) was performed according to the company's instruction. Brie¯y, 2.5 milligrams of peptides dissolved in 2 ml of 50 mM HEPES, pH 7.2 was mixed with 1 ml of prewashed Agel-15 agarose, and then incubated end-over-end for 1 h at room temperature. Coupling of preimmune serum or DNase 1 (Sigma, USA) to Agel-15 was also performed in the same manner.
[
35 S]methionine/cysteine metabolic labeling and anity puri®cation of labeled proteins Cells were labeled in methionine/cystein-free MCDB 104 medium supplemented with 100 mCi/ml of [ 35 S]methionine/ cysteine Promix (Amersham) for 2 h at 378C. The labeled cells were washed three times with ice-cold 20 mM Tris, pH 7.4, 150 mM NaCl, lysed in ice-cold RIPA buer (20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM phenylmethylsulfonyl¯uoride (PMSF), 1% aprotinin and 200 mM Na 3 VO 4 ); insoluble material was removed by centrifugation at 13 000 g for 10 min at 48C. The lysates were precleared by incubation for 30 min at 48C with nonimmune serum coupled to agarose. The lysates were then incubated with phosphorylated or unphosphorylated peptides immobilized on agarose, in the presence or absence of free competing peptide, for 1 h at 48C. Thereafter the agarose beads were washed twice with RIPA buer, four times with a RIPA buer supplemented with 500 mM NaCl (high salt RIPA), and once again with RIPA buer. Then the bound proteins were eluted by heating at 958C in SDS-sample buer (4% SDS, 0.2 M Tris-HCl, pH 8.8, 0.5 M sucrose, 5 mM EDTA, 0.1% bromophenol blue, 2% 2-mercaptoethanol), analysed by SDS ± PAGE, dried, and subjected to¯uorography.
Large scale puri®cation, in gel digestion and amino acid sequencing of the puri®ed proteins Larger amount of proteins were puri®ed from HeLa cell lysate by use of peptide-coupled agarose essentially according to Hansen et al. (1996) . Brie¯y, approximately 1610 10 HeLa cells grown in suspension culture were lysed in a RIPA buer as described above to give a ®nal volume of 200 ml. The lysate was cleared by high-speed centrifugation (13 000 g) for 30 min at 48C, followed by ultracentrifugation at 100 000 g for another 30 min. The lysate was further cleared by incubation for 1 h at 48C with a rabbit nonimmune serum coupled to agarose and then with DNase 1-coupled agarose for 1 h. Glycerol was then added to the precleared lysate to a ®nal concentration of 8%, and the lysates were frozen at 7708C overnight. The lysate was thawed, cleared again by ultracentrifugation and incubated with non-immune serum-coupled agarose. The cleared lysate was then incubated end-over-end with pY762 peptide coupled to agarose for 3 h at 48C. After the incubation, the beads were washed extensively in normal and high salt RIPA buer as described above. The bound material was then eluted from the beads by addition of free pY762 peptide to a ®nal concentration of 200 mM. The eluate was denatured, reduced by heating at 958C in SDS-sample buer supplemented with 10 mM dithiothreitol, and then alkylated in 25 mM iodoacetamide. The proteins were puri®ed by SDS ± PAGE using a 5 ± 20% gradient polyacrylamide gel.
After electrophoresis, the proteins were stained with Coomassie Blue R-250, and the protein bands of interest were excised from the wet gel. The gel pieces were then treated essentially as described in Hellman et al., (1995) . Brie¯y, the gel pieces were washed with 0.1 M Tris-HCl buer, pH 9.2, containing 50% acetonitrile, and then dried thoroughly. Half a microgram of endoproteinase LysC (WAKO Chemicals, Japan) was allowed to absorb into the rehydrating gel pieces, which were then incubated overnight. The proteolytic fragments were then extracted from the gel pieces and isolated by narrow bore reversed phase liquid chromatography on a mRPC C2/C18 SC 2.1/10 column, operated in a SMART System (Pharmacia Biotech, Sweden). Several peptides were subjected to automated Edman degradation in an Applied Biosystems Model 470A sequencer, operated according to the manufacturer's instruction.
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting were performed essentially as previously described (Yokote et al., 1994) . Serum-starved cells were treated with PDGF-BB, rinsed once with ice-cold phosphate-buered saline (PBS), and then lysed in an NP-40 lysis buer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 2.5 mM EDTA, 500 mM Na 3 VO 4 , 1% aprotinin and 1 mM PMSF). For immunoprecipitation, the lysates were incubated with 1 mg per sample of antibody for 2 h at 48C, followed by incubation with Protein A-Sepharose 6MB (Pharmacia) for 30 min at 48C. The immunoprecipitates were washed three times in lysis buer, eluted by boiling in SDS-sample buer, and subjected to SDS ± PAGE. In some experiments, cell lysates were incubated with various concentrations of synthetic peptides at 48C for 1 h, prior to addition of antibodies for immunoprecipitation. To enrich a glycoprotein fraction, wheat germ agglutinin (WGA, Wheat germ lectin Sepharose 6MB, Pharmacia) was used. In this case, the Sepharose beads were prewashed with ice-cold PBS three times, incubated with the lysates for 2 h at 48C, and washed three times in the lysis buer; the bound material was then eluted and subjected to SDS ± PAGE.
For immunoblotting, the samples were electrically transferred from the acrylamide gel onto a nitrocellulose ®lter (Hybond-C extra, Amersham), followed by blocking in PBS containing 5% bovine serum albumin (BSA) and 0.2% Tween-20. The blots were then incubated with 1 mg/ml of antibodies. The blots were washed and then incubated with the peroxidase-conjugated sheep anti-mouse (1 : 1000 dilution) or donkey anti-rabbit (1 : 5000 dilution) immunoglobulins. After washing, the sites of antibody-binding were visualized using the ECL Western blotting detection system (Amersham). After removal of the ®rst probe by incubation in 5 mM sodium phosphate, pH 7.5, 2% SDS and 2 mM 2-mercaptoethanol for 30 min at 608C, the blots were reprobed using another antibody.
H]thymidine incorporation assay
The ability of PDGF-BB to stimulate DNA synthesis, measured by the incorporation of [ 3 H]thymidine, in the dierent transfected cell lines was performed as described previously by Mori et al., (1993) . Brie¯y, cells seeded sparsely in 12-well plates were grown for 2 days, and while the cells were still subcon¯uent, the medium was changed to a serum-free medium. After 48 h of serum starvation, 0.5 mCi [ 3 H]thymidine/ml (Amersham) and PDGF-BB (0 ± 20 ng/ml) or 5% FBS were added. After incubation for 24 h, the cells were washed and high molecular mass radioactivity was precipitated with 5% trichloroacetic acid. The precipitate was washed and solubilized, and 3 Hradioactivity was measured in a liquid scintillation counter.
MAP (mitogen-activated protein) kinase assay
Serum-starved cells were treated with 50 ng/ml PDGF-BB for 5 min at 378C, and then lysed in the NP-40 lysis buer described above, supplemented with 1 mM dithiothreitol and 20 mM sodium¯uoride. The lysates were precleared, and immunoprecipitation was performed using a peptide antiserum denoted EET raised against a carboxyterminal sequence (EETARFQPGYRS) of MAP2 kinase. The immunoprecipitates were washed three times with the lysis buer and twice with a kinase buer (20 mM HEPES, pH 7.5, 10 mM MgCl 2 , 2 mM MnCl 2 , 100 mM Na 3 VO 4 and 1 mM dithiothreitol). Samples were subjected to a kinase assay in 25 ml of kinase buer supplemented with 10 mg myelin basic protein (Sigma), 10 mM protein kinase inhibitor (PKI, Sigma), and 5 mCi [g-32 P]ATP (Amersham Corp.). Incubation was continued for 15 min at 308C, and the reaction was terminated by addition of SDS-sample buer. The samples were subjected to SDS ± PAGE in a 15% polycacrylamide gel and were analysed by autoradiography. For quanti®cation of radioactivity, a Bioimage analyser BAS 2000 (Fuji ®lm, Japan) was used.
